Explore BrainMass

Prostate Cancer Chemoprevention

This content was STOLEN from BrainMass.com - View the original, and get the solution, here!

Can anyone assist me with this recent article please?

The topic is : Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as the "second human genome. The article first published online: 16 APR 2012. Hideyuki Akaza* DOI: 10.1111/j.1349-7006.2012.02257.x.

Here is an excerpt from the conclusion:

"In recent years there has been a noticeable increase in interest in prostate cancer chemoprevention. However, even with regard to 5-reductase inhibitors, the effectiveness of which has been proven with well-documented evidence, given concerns about pathological results that showed a higher occurrence rate in the inhibitor-administrated groups than for the control groups and also about specific drug side effects, and also considering the issue of additional expenses for medical systems, these inhibitors have yet to receive general support for use against high grade cancers."

In APA Format. What is your reaction to this information? Does it help inform your response? incorporate the epidemiologic concepts, particular method of prevention is effective or not.

© BrainMass Inc. brainmass.com September 20, 2018, 1:20 pm ad1c9bdddf - https://brainmass.com/health-sciences/topics-in-health-and-wellness/prostate-cancer-chemoprevention-521252

Solution Preview

The attached document is by no means intended as a homework or assignment completion. It is an example of how the response to the above question might be addressed. Additional ideas to include are provided in the notes section.

Prostate cancer is a serious illness that sometimes requires aggressive treatment and
management. According to the National Cancer Institute, "it is estimated that 241,740 men will
be diagnosed with and 28,170 men will die of cancer of the prostate in 2012". It is
understandable that health officials and health care providers wish to include prevention as part
of routine care for their male patients over the age of 44, when the incidence of prostate cancer
becomes statistically relevant. However, the evidence presented by Asaka (2012) appears to
be ...

Solution Summary

The solution discusses prostate cancer chemoprevention.